Clinical characteristics of hepatic Arterioportal shunts associated with hepatocellular carcinoma
Abstract Background Hepatic arterioportal shunt (A-P shunt) is defined as the direct blood flow established between hepatic artery and portal venous system; it is frequently observed in patients with hepatocellular carcinoma (HCC). Clinically, it is important to diagnose HCC associated A-P shunts, a...
Main Authors: | , , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2018-11-01
|
Series: | BMC Gastroenterology |
Subjects: | |
Online Access: | http://link.springer.com/article/10.1186/s12876-018-0899-3 |
id |
doaj-2ac86a68872443da9615e125d1867576 |
---|---|
record_format |
Article |
spelling |
doaj-2ac86a68872443da9615e125d18675762020-11-25T02:36:41ZengBMCBMC Gastroenterology1471-230X2018-11-011811610.1186/s12876-018-0899-3Clinical characteristics of hepatic Arterioportal shunts associated with hepatocellular carcinomaHuiyong Wu0Wei Zhao1Jianbo Zhang2Jianjun Han3Shuguang Liu4Department of Intervention, Shandong Tumor Hospital Affiliated to Shandong UniversityDepartment of Radiotherapy, Shandong Tumor Hospital Affiliated to Shandong UniversityDepartment of pathology, Shandong Tumor Hospital Affiliated to Shandong UniversityDepartment of Intervention, Shandong Tumor Hospital Affiliated to Shandong UniversityDepartment of Thoracic Oncology Surgery, Shandong Tumor Hospital Affiliated to Shandong UniversityAbstract Background Hepatic arterioportal shunt (A-P shunt) is defined as the direct blood flow established between hepatic artery and portal venous system; it is frequently observed in patients with hepatocellular carcinoma (HCC). Clinically, it is important to diagnose HCC associated A-P shunts, as it may impact the treatment strategy of the patients. In the present study, we described the imaging findings of the HCC associated A-P shunts and discussed the treatments strategy of such patients. From the findings, we also discussed the potential cause of A-P shunts. Methods Clinical data of HCC patients (n = 560), admitted to the hospital between April 2012 to April 2014, were reviewed. Hepatic angiography was used to examine the presence of A-P shunts. Of the 137 patients with A-P shunts, grading of the A-P shunts was performed, and statistical analysis of the different grades of A-P shunts and clinical characteristics was performed. Results The hepatic angiography confirmed that 99 patients had typical A-P shunts (Grade 1–3), and 38 patients had atypical A-P shunts. Embolization was the main strategy used to treat A-P shunts, in which liquid embolic agents appeared to provide a better treatment outcome. The correlation analysis showed that the grading of portal vein tumor thrombus was significantly associated with the grading of A-P shunt (p = < 0.001, Spearman correlation coefficient was 0.816 ± 0.043). Conclusions We characterized A-P shunts and proposed treatment strategy for treating HCC patients with various levels of A-P shunts. The findings supported the hypothesis that the formation of HCC associated A-P shunts was caused by tumor thrombus.http://link.springer.com/article/10.1186/s12876-018-0899-3Hepatocellular carcinomaHepatic arterioportal shuntsPortal vein tumor embolusTransarterial chemoembolization |
collection |
DOAJ |
language |
English |
format |
Article |
sources |
DOAJ |
author |
Huiyong Wu Wei Zhao Jianbo Zhang Jianjun Han Shuguang Liu |
spellingShingle |
Huiyong Wu Wei Zhao Jianbo Zhang Jianjun Han Shuguang Liu Clinical characteristics of hepatic Arterioportal shunts associated with hepatocellular carcinoma BMC Gastroenterology Hepatocellular carcinoma Hepatic arterioportal shunts Portal vein tumor embolus Transarterial chemoembolization |
author_facet |
Huiyong Wu Wei Zhao Jianbo Zhang Jianjun Han Shuguang Liu |
author_sort |
Huiyong Wu |
title |
Clinical characteristics of hepatic Arterioportal shunts associated with hepatocellular carcinoma |
title_short |
Clinical characteristics of hepatic Arterioportal shunts associated with hepatocellular carcinoma |
title_full |
Clinical characteristics of hepatic Arterioportal shunts associated with hepatocellular carcinoma |
title_fullStr |
Clinical characteristics of hepatic Arterioportal shunts associated with hepatocellular carcinoma |
title_full_unstemmed |
Clinical characteristics of hepatic Arterioportal shunts associated with hepatocellular carcinoma |
title_sort |
clinical characteristics of hepatic arterioportal shunts associated with hepatocellular carcinoma |
publisher |
BMC |
series |
BMC Gastroenterology |
issn |
1471-230X |
publishDate |
2018-11-01 |
description |
Abstract Background Hepatic arterioportal shunt (A-P shunt) is defined as the direct blood flow established between hepatic artery and portal venous system; it is frequently observed in patients with hepatocellular carcinoma (HCC). Clinically, it is important to diagnose HCC associated A-P shunts, as it may impact the treatment strategy of the patients. In the present study, we described the imaging findings of the HCC associated A-P shunts and discussed the treatments strategy of such patients. From the findings, we also discussed the potential cause of A-P shunts. Methods Clinical data of HCC patients (n = 560), admitted to the hospital between April 2012 to April 2014, were reviewed. Hepatic angiography was used to examine the presence of A-P shunts. Of the 137 patients with A-P shunts, grading of the A-P shunts was performed, and statistical analysis of the different grades of A-P shunts and clinical characteristics was performed. Results The hepatic angiography confirmed that 99 patients had typical A-P shunts (Grade 1–3), and 38 patients had atypical A-P shunts. Embolization was the main strategy used to treat A-P shunts, in which liquid embolic agents appeared to provide a better treatment outcome. The correlation analysis showed that the grading of portal vein tumor thrombus was significantly associated with the grading of A-P shunt (p = < 0.001, Spearman correlation coefficient was 0.816 ± 0.043). Conclusions We characterized A-P shunts and proposed treatment strategy for treating HCC patients with various levels of A-P shunts. The findings supported the hypothesis that the formation of HCC associated A-P shunts was caused by tumor thrombus. |
topic |
Hepatocellular carcinoma Hepatic arterioportal shunts Portal vein tumor embolus Transarterial chemoembolization |
url |
http://link.springer.com/article/10.1186/s12876-018-0899-3 |
work_keys_str_mv |
AT huiyongwu clinicalcharacteristicsofhepaticarterioportalshuntsassociatedwithhepatocellularcarcinoma AT weizhao clinicalcharacteristicsofhepaticarterioportalshuntsassociatedwithhepatocellularcarcinoma AT jianbozhang clinicalcharacteristicsofhepaticarterioportalshuntsassociatedwithhepatocellularcarcinoma AT jianjunhan clinicalcharacteristicsofhepaticarterioportalshuntsassociatedwithhepatocellularcarcinoma AT shuguangliu clinicalcharacteristicsofhepaticarterioportalshuntsassociatedwithhepatocellularcarcinoma |
_version_ |
1724798645225652224 |